Growth-oriented investor and operating executive with experience in healthcare and enterprise software, focused on scaling commercial models and board governance. Stephanie Ternes brings a background blending strategy, corporate development and investor relations, advising growth-stage companies on capital formation, go-to-market execution and M&A positioning for private and public market outcomes.
Growth-oriented investor and operating executive with experience in healthcare and enterprise software, focused on scaling commercial models and board governance. Stephanie Ternes brings a background blending strategy, corporate development and investor relations, advising growth-stage companies on capital formation, go-to-market execution and M&A positioning for private and public market outcomes.
Operates as a growth-oriented, operator-investor who prioritizes commercial scalability and durable go-to-market advantages in healthcare and enterprise software. Prefers minority and growth equity positions that pair capital with active board-level governance and commercialization support. Underwrites opportunities on market size, predictable unit economics, and repeatable sales motion, emphasizing capital-efficient GTM and M&A optionality. Time horizon is medium-to-long; risk discipline centers on validated demand, management alignment, and clear exit pathways via strategic sale or public markets.
Operates as a growth-oriented, operator-investor who prioritizes commercial scalability and durable go-to-market advantages in healthcare and enterprise software. Prefers minority and growth equity positions that pair capital with active board-level governance and commercialization support. Underwrites opportunities on market size, predictable unit economics, and repeatable sales motion, emphasizing capital-efficient GTM and M&A optionality. Time horizon is medium-to-long; risk discipline centers on validated demand, management alignment, and clear exit pathways via strategic sale or public markets.
| Trades 289 | Longs Won 231/289 79% | Profit Factor 22.6 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $739,227.19 |
| Average Win $206,574.31 | Best Trade (Oct 15) $7.28M | Sharpe Ratio -13.89 |
| Average Loss -$36,405.78 | Worst Trade (Oct 15) -$509,857.75 | Z-Score 11 (100%) |
| Commissions $0 | Avg. Trade Length 1y 4m 2w 3d | Expectancy $157,810.14 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% |
| Consecutive Losing Trades | 5,556 | 5,000 | 4,444 | 3,889 | 3,333 | 2,778 | 2,222 | 1,667 | 1,111 | 556 |
| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
AAPL Apple Inc. | 13,292 | $2.64M | $4.59M | - | $1.95M | 73.8% | +0.965% |
ALRS Alerus Financial Corporation | 50,279 | $1.13M | $1.55M | - | $428,376.91 | 38.05% | +0.651% |
AMZN Amazon.com Inc | 1,351 | $300,566.24 | $342,964.86 | - | $42,398.62 | 14.11% | -0.353% |
AOA iShares Core Aggressive Allocation ETF | 35,042 | $2.76M | $3.41M | - | $651,283.28 | 23.59% | -0.092% |
AOK iShares Core Conservative Allocation ETF | 15,197 | $551,533.32 | $616,466.3 | - | $64,932.98 | 11.77% | -0.037% |
AOM iShares Core 40/60 Moderate Allocation ETF | 12,335 | $533,785.9 | $602,133.02 | - | $68,347.12 | 12.8% | -0.072% |
AOR iShares Core 60/40 Balanced Allocation ETF | 86,813 | $4.67M | $5.96M | - | $1.29M | 27.54% | -0.066% |
BKAG BNY Mellon Core Bond ETF | 212,034 | $9.03M | $8.56M | - | -$470,888.29 | -5.22% | +0.074% |
BKIE BNY Mellon International Equity ETF | 213,216 | $6.38M | $7.14M | - | $760,710.7 | 11.92% | +0.54% |
BKLC BNY Mellon US Large Cap Core Equity ETF | 107,595 | $4.04M | $5.29M | - | $1.25M | 30.87% | -0.395% |
BRK-B Berkshire Hathaway Inc. | 2,360 | $889,167.16 | $1.25M | - | $361,467.64 | 40.65% | +0.808% |
BSV Vanguard Short-Term Bond ETF | 9,001 | $697,621.18 | $689,746.63 | - | -$7,874.55 | -1.13% | +0.091% |
DKNG DraftKings Inc. | 10,974 | $368,073.48 | $206,585.55 | - | -$161,487.93 | -43.87% | -2.512% |
EEM iShares MSCI Emerging Markets ETF | 7,350 | $305,757.02 | $465,218.25 | - | $159,461.23 | 52.15% | -1.04% |
FNDA Schwab Fundamental U.S. Small Company ETF | 603,841 | $16.95M | $21.45M | - | $4.51M | 26.61% | -0.281% |
FNDE Schwab Fundamental Emerging Markets Large Company Index ETF | 178,420 | $5.04M | $7.59M | - | $2.54M | 50.46% | -0.387% |
FNDF Schwab Fundamental International Large Company Index ETF | 7,468 | $318,576.78 | $404,578.9 | - | $86,002.12 | 27% | +0.828% |
FNDX Schwab Fundamental U.S. Large Company Index ETF | 619,404 | $13.84M | $20.2M | - | $6.36M | 45.96% | +0.123% |
GE General Electric Company | 554 | $207,046 | $175,750.96 | - | -$31,295.04 | -15.12% | +1.679% |
GEV GE Vernova Inc. | 184 | $216,174 | $170,821.92 | - | -$45,352.08 | -20.98% | +0.209% |